XML 89 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Jul. 31, 2022
Dec. 31, 2022
Jul. 01, 2022
Acquired Finite-Lived Intangible Assets [Line Items]      
Amortization of Intangible Assets   $ 37.6  
Finite-lived intangible asset, expected amortization, year one   72.0  
Finite-lived intangible asset, expected amortization, year two   72.0  
Finite-lived intangible asset, expected amortization, year three   72.0  
Finite-lived intangible asset, expected amortization, year four   72.0  
Finite-lived intangible asset, expected amortization, year five   $ 72.0  
Sanofi Collaboration Agreement, Amended and Restated Immuno-oncology License and Collaboration Agreement      
Acquired Finite-Lived Intangible Assets [Line Items]      
Other Liabilities     $ 241.0
Sanofi      
Acquired Finite-Lived Intangible Assets [Line Items]      
Up-front payment to collaborating party $ 900.0